Brian Howard Eisner, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Calculi | 49 | 2023 | 465 | 11.430 |
Why?
|
Ureteral Calculi | 27 | 2023 | 110 | 9.650 |
Why?
|
Ureteroscopy | 34 | 2023 | 142 | 7.190 |
Why?
|
Nephrolithiasis | 23 | 2019 | 110 | 7.150 |
Why?
|
Nephrostomy, Percutaneous | 16 | 2023 | 85 | 5.410 |
Why?
|
Ureter | 16 | 2023 | 375 | 4.710 |
Why?
|
Lithotripsy | 14 | 2023 | 143 | 4.590 |
Why?
|
Urolithiasis | 17 | 2023 | 131 | 4.240 |
Why?
|
Renal Colic | 6 | 2020 | 31 | 2.640 |
Why?
|
Lithotripsy, Laser | 8 | 2023 | 46 | 1.740 |
Why?
|
Urinary Calculi | 9 | 2021 | 91 | 1.600 |
Why?
|
Ureteral Neoplasms | 7 | 2023 | 111 | 1.570 |
Why?
|
Ureteroscopes | 2 | 2022 | 23 | 1.550 |
Why?
|
Calcium Oxalate | 8 | 2023 | 74 | 1.540 |
Why?
|
Citric Acid | 6 | 2015 | 126 | 1.280 |
Why?
|
Ureteral Obstruction | 5 | 2017 | 296 | 1.130 |
Why?
|
Urology | 6 | 2024 | 399 | 1.090 |
Why?
|
Stents | 11 | 2023 | 3280 | 1.060 |
Why?
|
Urinary Tract Infections | 6 | 2019 | 788 | 1.060 |
Why?
|
Urine | 4 | 2012 | 370 | 1.050 |
Why?
|
Urologic Diseases | 2 | 2019 | 244 | 1.040 |
Why?
|
Hydronephrosis | 3 | 2016 | 269 | 1.000 |
Why?
|
Kidney Medulla | 3 | 2015 | 182 | 0.930 |
Why?
|
Kidney Pelvis | 4 | 2023 | 188 | 0.930 |
Why?
|
Cystinuria | 2 | 2020 | 19 | 0.900 |
Why?
|
Thiazides | 2 | 2013 | 18 | 0.800 |
Why?
|
Carcinoma, Transitional Cell | 6 | 2023 | 808 | 0.790 |
Why?
|
Calcium | 5 | 2015 | 5756 | 0.720 |
Why?
|
Potassium Citrate | 2 | 2018 | 8 | 0.720 |
Why?
|
Lasers, Solid-State | 5 | 2023 | 169 | 0.700 |
Why?
|
Sepsis | 6 | 2023 | 2593 | 0.690 |
Why?
|
Disposable Equipment | 1 | 2019 | 43 | 0.690 |
Why?
|
Decision Support Techniques | 5 | 2016 | 1956 | 0.680 |
Why?
|
Shock, Septic | 2 | 2023 | 775 | 0.650 |
Why?
|
Tomography, X-Ray Computed | 24 | 2023 | 20129 | 0.650 |
Why?
|
Retrospective Studies | 58 | 2023 | 77449 | 0.630 |
Why?
|
Endoscopy | 5 | 2020 | 1785 | 0.620 |
Why?
|
Kidney Neoplasms | 11 | 2023 | 4262 | 0.610 |
Why?
|
Hydrodynamics | 1 | 2018 | 158 | 0.610 |
Why?
|
Humans | 154 | 2024 | 744343 | 0.560 |
Why?
|
Flank Pain | 1 | 2016 | 43 | 0.540 |
Why?
|
Calcium Phosphates | 2 | 2018 | 171 | 0.540 |
Why?
|
Hyperoxaluria | 2 | 2012 | 32 | 0.540 |
Why?
|
Antacids | 1 | 2015 | 99 | 0.530 |
Why?
|
Analgesics, Opioid | 3 | 2021 | 3674 | 0.520 |
Why?
|
Device Removal | 3 | 2021 | 656 | 0.510 |
Why?
|
Ureteral Diseases | 3 | 2013 | 61 | 0.510 |
Why?
|
Asymptomatic Diseases | 1 | 2017 | 551 | 0.490 |
Why?
|
Obesity, Morbid | 2 | 2016 | 1213 | 0.480 |
Why?
|
Nutrition Surveys | 3 | 2019 | 1660 | 0.480 |
Why?
|
Dehydration | 1 | 2015 | 234 | 0.460 |
Why?
|
Male | 88 | 2023 | 350118 | 0.460 |
Why?
|
Urinary Bladder Neoplasms | 5 | 2023 | 2245 | 0.450 |
Why?
|
Citrates | 2 | 2011 | 131 | 0.450 |
Why?
|
Female | 90 | 2023 | 380194 | 0.450 |
Why?
|
Radiography, Dual-Energy Scanned Projection | 3 | 2022 | 197 | 0.440 |
Why?
|
Nomograms | 1 | 2014 | 228 | 0.430 |
Why?
|
Circadian Rhythm | 4 | 2012 | 2624 | 0.430 |
Why?
|
Comprehension | 1 | 2018 | 610 | 0.420 |
Why?
|
Carbonated Beverages | 2 | 2011 | 214 | 0.420 |
Why?
|
Postoperative Care | 3 | 2015 | 1486 | 0.420 |
Why?
|
Kidney Diseases | 4 | 2011 | 2149 | 0.420 |
Why?
|
Middle Aged | 63 | 2023 | 213383 | 0.410 |
Why?
|
Prescription Drugs | 1 | 2019 | 595 | 0.410 |
Why?
|
Allopurinol | 1 | 2013 | 191 | 0.400 |
Why?
|
Kidney Tubules | 1 | 2013 | 488 | 0.400 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2015 | 2208 | 0.400 |
Why?
|
Sodium | 3 | 2015 | 1623 | 0.390 |
Why?
|
Vasectomy | 2 | 2017 | 52 | 0.380 |
Why?
|
Malates | 1 | 2010 | 33 | 0.370 |
Why?
|
Obesity, Abdominal | 1 | 2013 | 361 | 0.370 |
Why?
|
Alkalies | 1 | 2010 | 52 | 0.370 |
Why?
|
Urinalysis | 6 | 2012 | 369 | 0.370 |
Why?
|
Radiation Dosage | 7 | 2023 | 1928 | 0.370 |
Why?
|
Body Mass Index | 3 | 2016 | 12720 | 0.360 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 7 | 2019 | 1184 | 0.360 |
Why?
|
Kidney Calices | 1 | 2009 | 26 | 0.360 |
Why?
|
Hyperparathyroidism, Primary | 2 | 2009 | 160 | 0.360 |
Why?
|
Oxalates | 1 | 2010 | 105 | 0.350 |
Why?
|
Obstetric Labor Complications | 1 | 2012 | 238 | 0.350 |
Why?
|
Laparoscopy | 6 | 2013 | 2151 | 0.350 |
Why?
|
Urogenital Neoplasms | 2 | 2009 | 137 | 0.350 |
Why?
|
Chyle | 1 | 2009 | 16 | 0.350 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2010 | 93 | 0.350 |
Why?
|
Radiation Protection | 3 | 2013 | 419 | 0.350 |
Why?
|
Drug Prescriptions | 1 | 2019 | 1637 | 0.350 |
Why?
|
Kidney | 7 | 2022 | 7186 | 0.350 |
Why?
|
Urologic Surgical Procedures | 4 | 2017 | 302 | 0.350 |
Why?
|
Colic | 1 | 2009 | 42 | 0.350 |
Why?
|
Treatment Outcome | 25 | 2023 | 63114 | 0.340 |
Why?
|
Magnesium | 1 | 2012 | 813 | 0.340 |
Why?
|
Ultrasonography | 4 | 2017 | 5985 | 0.330 |
Why?
|
Emergency Service, Hospital | 5 | 2023 | 7659 | 0.330 |
Why?
|
Pain Measurement | 3 | 2016 | 3420 | 0.330 |
Why?
|
Robotics | 3 | 2013 | 899 | 0.320 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2009 | 126 | 0.310 |
Why?
|
Adult | 51 | 2023 | 214055 | 0.300 |
Why?
|
Fistula | 1 | 2009 | 220 | 0.300 |
Why?
|
Pressure | 2 | 2022 | 1203 | 0.300 |
Why?
|
Foreign-Body Migration | 1 | 2009 | 222 | 0.290 |
Why?
|
Mesenchymoma | 1 | 2006 | 47 | 0.290 |
Why?
|
Aged | 44 | 2023 | 163280 | 0.280 |
Why?
|
Prostatectomy | 2 | 2013 | 1890 | 0.280 |
Why?
|
Seasons | 1 | 2012 | 1493 | 0.280 |
Why?
|
Diet | 2 | 2015 | 7939 | 0.270 |
Why?
|
Swine | 4 | 2022 | 5917 | 0.260 |
Why?
|
Internet | 1 | 2018 | 3064 | 0.260 |
Why?
|
Beverages | 1 | 2011 | 820 | 0.260 |
Why?
|
Penile Neoplasms | 1 | 2006 | 160 | 0.260 |
Why?
|
Laser Therapy | 2 | 2023 | 1072 | 0.250 |
Why?
|
Guideline Adherence | 1 | 2015 | 2266 | 0.250 |
Why?
|
Vas Deferens | 1 | 2004 | 55 | 0.240 |
Why?
|
Glomerular Filtration Rate | 1 | 2012 | 2170 | 0.240 |
Why?
|
Oligospermia | 1 | 2004 | 59 | 0.240 |
Why?
|
Erythrocytes | 1 | 2013 | 2455 | 0.240 |
Why?
|
Postoperative Complications | 7 | 2019 | 15295 | 0.240 |
Why?
|
Anti-Bacterial Agents | 4 | 2018 | 7181 | 0.240 |
Why?
|
Internship and Residency | 2 | 2024 | 5788 | 0.230 |
Why?
|
Vitamins | 1 | 2012 | 1622 | 0.230 |
Why?
|
Catheters, Indwelling | 1 | 2006 | 426 | 0.230 |
Why?
|
Prevalence | 6 | 2023 | 15226 | 0.230 |
Why?
|
Sperm Count | 1 | 2004 | 216 | 0.230 |
Why?
|
Recurrence | 6 | 2015 | 8340 | 0.230 |
Why?
|
Tulipa | 1 | 2022 | 1 | 0.230 |
Why?
|
Foreign Medical Graduates | 1 | 2024 | 79 | 0.220 |
Why?
|
Diabetic Nephropathies | 1 | 2010 | 984 | 0.220 |
Why?
|
Eponyms | 1 | 2002 | 15 | 0.220 |
Why?
|
Hydrogen-Ion Concentration | 4 | 2023 | 2557 | 0.220 |
Why?
|
Prosthesis Failure | 2 | 2021 | 1206 | 0.220 |
Why?
|
Oxidative Stress | 1 | 2013 | 3086 | 0.210 |
Why?
|
Embryology | 1 | 2002 | 29 | 0.210 |
Why?
|
Cholinergic Antagonists | 1 | 2023 | 165 | 0.210 |
Why?
|
Mitomycin | 4 | 2023 | 259 | 0.210 |
Why?
|
Achievement | 1 | 2024 | 291 | 0.210 |
Why?
|
Uric Acid | 4 | 2023 | 766 | 0.210 |
Why?
|
Antibiotic Prophylaxis | 2 | 2018 | 639 | 0.200 |
Why?
|
C-Reactive Protein | 1 | 2013 | 3778 | 0.200 |
Why?
|
Kidney Failure, Chronic | 1 | 2014 | 2538 | 0.200 |
Why?
|
Pelvic Neoplasms | 1 | 2023 | 254 | 0.200 |
Why?
|
Equipment Design | 4 | 2012 | 3582 | 0.200 |
Why?
|
Hypercalciuria | 2 | 2012 | 31 | 0.190 |
Why?
|
Risk Assessment | 7 | 2017 | 23338 | 0.190 |
Why?
|
Systemic Inflammatory Response Syndrome | 2 | 2023 | 612 | 0.180 |
Why?
|
Cystine | 1 | 2020 | 95 | 0.180 |
Why?
|
Sex Characteristics | 1 | 2010 | 2585 | 0.180 |
Why?
|
Carcinoma, Renal Cell | 3 | 2010 | 3143 | 0.180 |
Why?
|
Multivariate Analysis | 5 | 2021 | 12245 | 0.170 |
Why?
|
Young Adult | 16 | 2021 | 56430 | 0.160 |
Why?
|
Nephrology | 1 | 2002 | 263 | 0.160 |
Why?
|
Vitamin D | 1 | 2012 | 3223 | 0.160 |
Why?
|
Factitious Disorders | 1 | 2018 | 41 | 0.160 |
Why?
|
Models, Statistical | 3 | 2013 | 5102 | 0.160 |
Why?
|
Risk Factors | 13 | 2021 | 72290 | 0.160 |
Why?
|
Prostatic Neoplasms | 3 | 2017 | 11124 | 0.150 |
Why?
|
Consensus | 3 | 2022 | 2959 | 0.150 |
Why?
|
Nanoparticles | 1 | 2009 | 1905 | 0.150 |
Why?
|
Lymph Nodes | 1 | 2009 | 3474 | 0.150 |
Why?
|
Diabetes Mellitus | 2 | 2015 | 5751 | 0.150 |
Why?
|
Urinary Tract | 1 | 2020 | 309 | 0.150 |
Why?
|
Narcotics | 1 | 2019 | 343 | 0.150 |
Why?
|
Diagnostic Imaging | 1 | 2011 | 3507 | 0.140 |
Why?
|
Incidence | 8 | 2021 | 20947 | 0.140 |
Why?
|
Follow-Up Studies | 10 | 2020 | 39050 | 0.140 |
Why?
|
Aged, 80 and over | 15 | 2021 | 57776 | 0.140 |
Why?
|
Body Size | 1 | 2019 | 461 | 0.140 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2019 | 687 | 0.130 |
Why?
|
Constriction, Pathologic | 3 | 2023 | 1107 | 0.130 |
Why?
|
Vasodilator Agents | 1 | 2019 | 977 | 0.130 |
Why?
|
Bayes Theorem | 1 | 2023 | 2309 | 0.130 |
Why?
|
ROC Curve | 1 | 2023 | 3527 | 0.130 |
Why?
|
Holmium | 3 | 2023 | 30 | 0.130 |
Why?
|
Radiographic Image Enhancement | 2 | 2010 | 885 | 0.120 |
Why?
|
Cost-Benefit Analysis | 4 | 2016 | 5391 | 0.120 |
Why?
|
Muscle Contraction | 1 | 2019 | 1240 | 0.120 |
Why?
|
Lasers | 2 | 2009 | 952 | 0.120 |
Why?
|
Hypertension | 2 | 2015 | 8480 | 0.120 |
Why?
|
Kallikreins | 1 | 2015 | 258 | 0.120 |
Why?
|
Intensive Care Units | 3 | 2023 | 3679 | 0.120 |
Why?
|
Self Report | 3 | 2021 | 3558 | 0.110 |
Why?
|
Urease | 1 | 2013 | 42 | 0.110 |
Why?
|
Predictive Value of Tests | 4 | 2016 | 15076 | 0.110 |
Why?
|
Ureterolithiasis | 1 | 2012 | 2 | 0.110 |
Why?
|
Time Factors | 10 | 2021 | 40075 | 0.110 |
Why?
|
Urologic Neoplasms | 1 | 2016 | 318 | 0.110 |
Why?
|
Thulium | 2 | 2023 | 21 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 2 | 2010 | 35421 | 0.100 |
Why?
|
Hospital Mortality | 2 | 2023 | 5317 | 0.100 |
Why?
|
Urography | 2 | 2013 | 313 | 0.100 |
Why?
|
Sex Distribution | 2 | 2015 | 2297 | 0.100 |
Why?
|
Severity of Illness Index | 5 | 2015 | 15540 | 0.100 |
Why?
|
Citrus sinensis | 1 | 2011 | 16 | 0.100 |
Why?
|
United States | 6 | 2023 | 69872 | 0.100 |
Why?
|
Prospective Studies | 11 | 2023 | 53288 | 0.100 |
Why?
|
Diagnosis, Differential | 3 | 2016 | 12959 | 0.100 |
Why?
|
Humidity | 1 | 2012 | 197 | 0.100 |
Why?
|
Potassium | 1 | 2015 | 1336 | 0.100 |
Why?
|
Benchmarking | 1 | 2018 | 1042 | 0.100 |
Why?
|
Linear Models | 2 | 2012 | 5952 | 0.100 |
Why?
|
Nephrocalcinosis | 1 | 2011 | 48 | 0.100 |
Why?
|
Prognosis | 5 | 2023 | 29063 | 0.100 |
Why?
|
Pain, Postoperative | 1 | 2021 | 1643 | 0.090 |
Why?
|
Animals | 8 | 2022 | 168757 | 0.090 |
Why?
|
Rupture, Spontaneous | 1 | 2011 | 354 | 0.090 |
Why?
|
Intestinal Absorption | 1 | 2012 | 420 | 0.090 |
Why?
|
Technetium Tc 99m Mertiatide | 1 | 2010 | 22 | 0.090 |
Why?
|
Nephrogenic Fibrosing Dermopathy | 1 | 2010 | 42 | 0.090 |
Why?
|
Postoperative Period | 3 | 2023 | 1842 | 0.090 |
Why?
|
Radiopharmaceuticals | 2 | 2010 | 2645 | 0.090 |
Why?
|
Supine Position | 2 | 2020 | 205 | 0.090 |
Why?
|
Diet Therapy | 1 | 2011 | 154 | 0.090 |
Why?
|
International Cooperation | 1 | 2016 | 1420 | 0.090 |
Why?
|
Cardiovascular Diseases | 1 | 2015 | 15165 | 0.090 |
Why?
|
Nephrectomy | 3 | 2010 | 1050 | 0.090 |
Why?
|
Health Personnel | 1 | 2023 | 3218 | 0.090 |
Why?
|
Myocardial Revascularization | 1 | 2013 | 841 | 0.080 |
Why?
|
Cystoscopy | 1 | 2009 | 134 | 0.080 |
Why?
|
Academic Medical Centers | 2 | 2010 | 2759 | 0.080 |
Why?
|
Calcium, Dietary | 1 | 2012 | 526 | 0.080 |
Why?
|
Quality of Life | 5 | 2023 | 12804 | 0.080 |
Why?
|
Sex Factors | 3 | 2018 | 10397 | 0.080 |
Why?
|
Ureterostomy | 1 | 2008 | 17 | 0.080 |
Why?
|
Tomography, Spiral Computed | 1 | 2010 | 280 | 0.080 |
Why?
|
Pain | 1 | 2023 | 4986 | 0.080 |
Why?
|
Probability | 2 | 2010 | 2505 | 0.080 |
Why?
|
Lymphatic Diseases | 1 | 2009 | 324 | 0.080 |
Why?
|
Escherichia coli Infections | 1 | 2011 | 532 | 0.070 |
Why?
|
Standard of Care | 1 | 2011 | 564 | 0.070 |
Why?
|
Urinary Catheterization | 1 | 2008 | 202 | 0.070 |
Why?
|
Vascular System Injuries | 1 | 2011 | 250 | 0.070 |
Why?
|
Prostate-Specific Antigen | 2 | 2015 | 2494 | 0.070 |
Why?
|
Parathyroidectomy | 1 | 2009 | 235 | 0.070 |
Why?
|
Calcinosis | 1 | 2015 | 1499 | 0.070 |
Why?
|
Obesity | 3 | 2020 | 12745 | 0.070 |
Why?
|
Urologic Surgical Procedures, Male | 1 | 2006 | 75 | 0.070 |
Why?
|
Adolescent | 10 | 2021 | 85781 | 0.070 |
Why?
|
Intraoperative Care | 2 | 2015 | 767 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2012 | 2971 | 0.070 |
Why?
|
Arteriovenous Malformations | 1 | 2009 | 396 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2010 | 11725 | 0.070 |
Why?
|
Child | 7 | 2018 | 77709 | 0.070 |
Why?
|
Catheter Ablation | 2 | 2010 | 2758 | 0.070 |
Why?
|
Temperature | 1 | 2012 | 2206 | 0.070 |
Why?
|
Patient Care Planning | 1 | 2011 | 921 | 0.070 |
Why?
|
Age Factors | 3 | 2017 | 18370 | 0.070 |
Why?
|
Fluoroscopy | 1 | 2009 | 924 | 0.060 |
Why?
|
Cryosurgery | 1 | 2010 | 453 | 0.060 |
Why?
|
Sodium, Dietary | 1 | 2009 | 418 | 0.060 |
Why?
|
Early Detection of Cancer | 2 | 2017 | 3086 | 0.060 |
Why?
|
Models, Anatomic | 1 | 2009 | 691 | 0.060 |
Why?
|
Gadolinium | 1 | 2010 | 952 | 0.060 |
Why?
|
Medicare | 1 | 2023 | 6566 | 0.060 |
Why?
|
Logistic Models | 3 | 2015 | 13408 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5319 | 0.060 |
Why?
|
Remission Induction | 1 | 2010 | 2386 | 0.060 |
Why?
|
Suture Techniques | 1 | 2010 | 798 | 0.060 |
Why?
|
Cold Temperature | 1 | 2008 | 772 | 0.060 |
Why?
|
Ultrasonography, Doppler | 1 | 2006 | 458 | 0.060 |
Why?
|
Mitomycins | 1 | 2023 | 47 | 0.060 |
Why?
|
Demography | 1 | 2008 | 1656 | 0.060 |
Why?
|
Carotid Stenosis | 1 | 2011 | 854 | 0.060 |
Why?
|
Absorptiometry, Photon | 1 | 2009 | 1725 | 0.060 |
Why?
|
Pilot Projects | 3 | 2018 | 8324 | 0.060 |
Why?
|
Hospitalization | 1 | 2023 | 10262 | 0.060 |
Why?
|
Social Class | 1 | 2012 | 1999 | 0.060 |
Why?
|
Societies, Medical | 1 | 2015 | 3743 | 0.060 |
Why?
|
Therapeutic Irrigation | 1 | 2004 | 301 | 0.050 |
Why?
|
Radiography | 2 | 2015 | 7023 | 0.050 |
Why?
|
Vitamin D Deficiency | 1 | 2012 | 1343 | 0.050 |
Why?
|
Feasibility Studies | 3 | 2022 | 5078 | 0.050 |
Why?
|
Metabolic Diseases | 1 | 2009 | 658 | 0.050 |
Why?
|
Models, Biological | 1 | 2018 | 9583 | 0.050 |
Why?
|
Urinary Retention | 1 | 2003 | 111 | 0.050 |
Why?
|
History, 18th Century | 1 | 2002 | 214 | 0.050 |
Why?
|
Enzyme Inhibitors | 1 | 2013 | 3798 | 0.050 |
Why?
|
Nephrons | 1 | 2023 | 220 | 0.050 |
Why?
|
Semen | 1 | 2004 | 316 | 0.050 |
Why?
|
Sodium Chloride | 1 | 2004 | 625 | 0.050 |
Why?
|
Insurance Coverage | 1 | 2013 | 1901 | 0.050 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2022 | 168 | 0.050 |
Why?
|
Urothelium | 1 | 2022 | 277 | 0.050 |
Why?
|
Poisson Distribution | 1 | 2021 | 513 | 0.050 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3255 | 0.050 |
Why?
|
Germany | 1 | 2002 | 862 | 0.050 |
Why?
|
Phantoms, Imaging | 2 | 2022 | 2480 | 0.040 |
Why?
|
Angiogenesis Inhibitors | 1 | 2010 | 2038 | 0.040 |
Why?
|
Lymphoma, B-Cell | 1 | 2006 | 931 | 0.040 |
Why?
|
History, 19th Century | 1 | 2002 | 720 | 0.040 |
Why?
|
Technology | 1 | 2022 | 305 | 0.040 |
Why?
|
Delphi Technique | 1 | 2022 | 778 | 0.040 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2003 | 360 | 0.040 |
Why?
|
Nifedipine | 1 | 2019 | 226 | 0.040 |
Why?
|
Prone Position | 1 | 2020 | 194 | 0.040 |
Why?
|
Boston | 2 | 2009 | 9313 | 0.040 |
Why?
|
Escherichia coli | 1 | 2011 | 4217 | 0.040 |
Why?
|
Disease Management | 1 | 2009 | 2459 | 0.040 |
Why?
|
Prostatic Hyperplasia | 1 | 2003 | 523 | 0.040 |
Why?
|
Contrast Media | 3 | 2019 | 5300 | 0.040 |
Why?
|
Cohort Studies | 3 | 2010 | 40561 | 0.040 |
Why?
|
Coronary Disease | 1 | 2013 | 6077 | 0.040 |
Why?
|
Sus scrofa | 1 | 2019 | 437 | 0.040 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2003 | 1770 | 0.040 |
Why?
|
Genital Neoplasms, Female | 1 | 2003 | 523 | 0.040 |
Why?
|
Quality Improvement | 1 | 2013 | 3749 | 0.040 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2005 | 1101 | 0.040 |
Why?
|
Patient Positioning | 1 | 2020 | 324 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 1000 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 14722 | 0.040 |
Why?
|
Smoking | 1 | 2013 | 8987 | 0.040 |
Why?
|
Dietary Supplements | 1 | 2009 | 3297 | 0.030 |
Why?
|
Glucose | 1 | 2008 | 4397 | 0.030 |
Why?
|
Digital Rectal Examination | 1 | 2015 | 42 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2015 | 19905 | 0.030 |
Why?
|
Regression Analysis | 2 | 2015 | 6459 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2010 | 11031 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2017 | 684 | 0.030 |
Why?
|
Statistics, Nonparametric | 2 | 2012 | 2886 | 0.030 |
Why?
|
Emergency Treatment | 1 | 2019 | 517 | 0.030 |
Why?
|
Atherosclerosis | 1 | 2011 | 3445 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2023 | 3479 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18029 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 1375 | 0.030 |
Why?
|
Child, Preschool | 4 | 2009 | 41006 | 0.030 |
Why?
|
Databases, Factual | 2 | 2018 | 7729 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 783 | 0.030 |
Why?
|
Outpatients | 1 | 2020 | 1486 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2023 | 6538 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2013 | 11727 | 0.030 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2013 | 205 | 0.030 |
Why?
|
Iopamidol | 1 | 2012 | 191 | 0.030 |
Why?
|
Risk | 2 | 2015 | 9687 | 0.030 |
Why?
|
Creatinine | 1 | 2017 | 1919 | 0.030 |
Why?
|
Patient Admission | 1 | 2019 | 1380 | 0.030 |
Why?
|
Treatment Failure | 1 | 2017 | 2618 | 0.020 |
Why?
|
Emergencies | 1 | 2017 | 1170 | 0.020 |
Why?
|
Biopsy, Needle | 2 | 2006 | 1641 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2008 | 21746 | 0.020 |
Why?
|
Pregnancy | 1 | 2012 | 29144 | 0.020 |
Why?
|
Life Style | 1 | 2021 | 3835 | 0.020 |
Why?
|
Acute Disease | 1 | 2020 | 7149 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2008 | 9239 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3952 | 0.020 |
Why?
|
Subtraction Technique | 1 | 2012 | 525 | 0.020 |
Why?
|
Tensile Strength | 1 | 2010 | 335 | 0.020 |
Why?
|
Office Visits | 1 | 2013 | 598 | 0.020 |
Why?
|
CD-ROM | 1 | 2008 | 24 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7279 | 0.020 |
Why?
|
Alloys | 1 | 2008 | 122 | 0.020 |
Why?
|
Reoperation | 2 | 2008 | 4201 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2014 | 2110 | 0.020 |
Why?
|
England | 1 | 2008 | 522 | 0.020 |
Why?
|
Osteoporotic Fractures | 1 | 2012 | 401 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10252 | 0.020 |
Why?
|
Syndrome | 1 | 2013 | 3251 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3508 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2011 | 2029 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2010 | 2031 | 0.020 |
Why?
|
Surgical Instruments | 1 | 2008 | 395 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2015 | 2716 | 0.020 |
Why?
|
Organ Size | 1 | 2010 | 2252 | 0.020 |
Why?
|
Infant | 1 | 2006 | 35136 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2019 | 19229 | 0.010 |
Why?
|
Perfusion | 1 | 2008 | 1360 | 0.010 |
Why?
|
Biopsy | 1 | 2015 | 6756 | 0.010 |
Why?
|
Neoplasm, Residual | 1 | 2008 | 973 | 0.010 |
Why?
|
Catheterization | 1 | 2009 | 1470 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2019 | 5535 | 0.010 |
Why?
|
Age Distribution | 1 | 2009 | 2902 | 0.010 |
Why?
|
Libido | 1 | 2003 | 121 | 0.010 |
Why?
|
Intraoperative Period | 1 | 2003 | 520 | 0.010 |
Why?
|
Critical Care | 1 | 2015 | 2647 | 0.010 |
Why?
|
Length of Stay | 1 | 2015 | 6309 | 0.010 |
Why?
|
Mass Screening | 1 | 2017 | 5255 | 0.010 |
Why?
|
Image Enhancement | 1 | 2012 | 2921 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 9959 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2005 | 1850 | 0.010 |
Why?
|
Preoperative Care | 1 | 2009 | 2250 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3610 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2009 | 1392 | 0.010 |
Why?
|
Erectile Dysfunction | 1 | 2003 | 461 | 0.010 |
Why?
|
Software | 1 | 2012 | 4443 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2005 | 20822 | 0.010 |
Why?
|
Mastectomy | 1 | 2005 | 1793 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2011 | 13989 | 0.010 |
Why?
|
Algorithms | 1 | 2015 | 13881 | 0.010 |
Why?
|
Clinical Competence | 1 | 2010 | 4687 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2003 | 6365 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2005 | 11366 | 0.010 |
Why?
|
Physicians | 1 | 2010 | 4567 | 0.010 |
Why?
|